Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glenn L Gordon

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Missouri Medicine|November 12, 2009
Biologic therapy in Crohn's diseaseMichael D Williams, M Louay Omran, Glenn L Gordon
The American Journal of Gastroenterology|June 4, 2009
Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled studyEllen J Scherl, Ronald Pruitt, Glenn L Gordon, et al.
Digestive Diseases and Sciences|November 14, 2015
Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis RemissionGary R Lichtenstein, Glenn L Gordon, Salam Zakko, et al.
Journal of Clinical Gastroenterology|September 15, 2015
Once-daily Mesalamine Formulation for Maintenance of Remission in Ulcerative Colitis: A Randomized, Placebo-controlled Clinical TrialGlenn L Gordon, Salam Zakko, Uma Murthy, et al.
Postgraduate Medicine|February 11, 2016
Once-daily mesalamine granules for maintaining remission of ulcerative colitis: pooled analysis of efficacy, safety, and prognostic factorsSalam F Zakko, Glenn L Gordon, Uma Murthy, et al.
Inflammatory Bowel Diseases|May 20, 2015
Briakinumab for treatment of Crohn's disease: results of a randomized trialRemo Panaccione, William J Sandborn, Glenn L Gordon, et al.
Digestive Diseases and Sciences|September 21, 2015
Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or ProctosigmoiditisDavid T Rubin, William J Sandborn, Brian Bosworth, et al.
Gastroenterology|February 4, 2015
Budesonide foam induces remission in patients with mild to moderate ulcerative proctitis and ulcerative proctosigmoiditisWilliam J Sandborn, Brian Bosworth, Salam Zakko, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Missouri Medicine|November 12, 2009
Biologic therapy in Crohn's diseaseMichael D Williams, M Louay Omran, Glenn L Gordon
The American Journal of Gastroenterology|June 4, 2009
Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled studyEllen J Scherl, Ronald Pruitt, Glenn L Gordon, et al.
Digestive Diseases and Sciences|November 14, 2015
Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis RemissionGary R Lichtenstein, Glenn L Gordon, Salam Zakko, et al.
Journal of Clinical Gastroenterology|September 15, 2015
Once-daily Mesalamine Formulation for Maintenance of Remission in Ulcerative Colitis: A Randomized, Placebo-controlled Clinical TrialGlenn L Gordon, Salam Zakko, Uma Murthy, et al.
Postgraduate Medicine|February 11, 2016
Once-daily mesalamine granules for maintaining remission of ulcerative colitis: pooled analysis of efficacy, safety, and prognostic factorsSalam F Zakko, Glenn L Gordon, Uma Murthy, et al.
Inflammatory Bowel Diseases|May 20, 2015
Briakinumab for treatment of Crohn's disease: results of a randomized trialRemo Panaccione, William J Sandborn, Glenn L Gordon, et al.
Digestive Diseases and Sciences|September 21, 2015
Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or ProctosigmoiditisDavid T Rubin, William J Sandborn, Brian Bosworth, et al.
Gastroenterology|February 4, 2015
Budesonide foam induces remission in patients with mild to moderate ulcerative proctitis and ulcerative proctosigmoiditisWilliam J Sandborn, Brian Bosworth, Salam Zakko, et al.
Pageof 1